T C Diss1, H X Liu, M Q Du, P G Isaacson. 1. Histopathology Department, Royal Free and University College Medical School, University Street, London WC1E 6JJ, UK. t.diss@ucl.ac.uk
Abstract
AIMS: Clonality analysis using polymerase chain reaction (PCR) amplification of the immunoglobulin heavy chain (IgH) gene is an important aid to the diagnosis of B cell lymphoproliferative diseases. However, the method has a relatively high false negative rate. In an attempt to improve detection rates simple PCR strategies for clonality analysis of B cell populations using amplification of Ig light chain genes have been developed. METHODS: Novel PCR protocols, designed to amplify Ig kappa and Ig lambda light chain genes, were evaluated using high molecular weight DNA samples from 28 selected cases of B cell lymphoma with known light chain expression and 12 reactive lymphoid specimens. Products were run on 10% polyacrylamide minigels using heteroduplex analysis. Conventional IgH PCR analysis was also performed. Twelve randomly selected formalin fixed, paraffin wax processed samples from cases submitted for molecular genetic analysis were also studied. RESULTS: Polyclonal products were seen in all reactive lymphoid samples. Using Ig kappa PCR, 24 of 28 lymphomas, including four of five IgH negative cases, displayed monoclonal patterns. Using Ig lambda PCR, eight of 12 Ig lambda expressing tumours, including two of five IgH negative cases, showed monoclonal patterns. Standard IgH PCR demonstrated monoclonality in 23 of 28 B cell lymphomas. The detection rate was improved to 27 of 28 lymphomas using heavy and light chain PCR. Efficient amplification was achieved using paraffin wax processed samples, seven of which showed monoclonality compared with eight using IgH PCR. CONCLUSIONS: Ig light chain PCR, used in conjunction with heavy chain analysis, enables improved detection of B cell monoclonality using routine histological specimens and can provide additional clone specific markers for the study of the biology of B cell tumours.
AIMS: Clonality analysis using polymerase chain reaction (PCR) amplification of the immunoglobulin heavy chain (IgH) gene is an important aid to the diagnosis of B cell lymphoproliferative diseases. However, the method has a relatively high false negative rate. In an attempt to improve detection rates simple PCR strategies for clonality analysis of B cell populations using amplification of Ig light chain genes have been developed. METHODS: Novel PCR protocols, designed to amplify Ig kappa and Ig lambda light chain genes, were evaluated using high molecular weight DNA samples from 28 selected cases of B cell lymphoma with known light chain expression and 12 reactive lymphoid specimens. Products were run on 10% polyacrylamide minigels using heteroduplex analysis. Conventional IgH PCR analysis was also performed. Twelve randomly selected formalin fixed, paraffin wax processed samples from cases submitted for molecular genetic analysis were also studied. RESULTS: Polyclonal products were seen in all reactive lymphoid samples. Using Ig kappa PCR, 24 of 28 lymphomas, including four of five IgH negative cases, displayed monoclonal patterns. Using Ig lambda PCR, eight of 12 Ig lambda expressing tumours, including two of five IgH negative cases, showed monoclonal patterns. Standard IgH PCR demonstrated monoclonality in 23 of 28 B cell lymphomas. The detection rate was improved to 27 of 28 lymphomas using heavy and light chain PCR. Efficient amplification was achieved using paraffin wax processed samples, seven of which showed monoclonality compared with eight using IgH PCR. CONCLUSIONS: Ig light chain PCR, used in conjunction with heavy chain analysis, enables improved detection of B cell monoclonality using routine histological specimens and can provide additional clone specific markers for the study of the biology of B cell tumours.
Authors: R García-Sanz; R López-Pérez; A W Langerak; D González; M C Chillón; A Balanzategui; M V Mateos; I Alaejos; M González; J J Van Dongen; J F San Miguel Journal: Haematologica Date: 1999-04 Impact factor: 9.941
Authors: M Q Du; H Liu; T C Diss; H Ye; R A Hamoudi; N Dupin; V Meignin; E Oksenhendler; C Boshoff; P G Isaacson Journal: Blood Date: 2001-04-01 Impact factor: 22.113
Authors: Claudia Mannu; Anna Gazzola; Francesco Bacci; Elena Sabattini; Carlo Sagramoso; Fernando Roncolato; Maura Rossi; Maria Antonella Laginestra; Maria Rosaria Sapienza; Claudio Agostinelli; Antonio De Leo; Milena Piccioli; Simona Righi; Patrizia Artioli; Luigi Chilli; Gianpaolo Da Pozzo; Giuseppe De Biase; Federica Sandri; Stefano A Pileri; Pier Paolo Piccaluga Journal: Am J Blood Res Date: 2011-09-12
Authors: Mark A Catherwood; David Gonzalez; Caroline Patton; Edwina Dobbin; Lakshmi Venkatraman; H Denis Alexander Journal: J Clin Pathol Date: 2006-06-30 Impact factor: 3.411
Authors: Cinque Soto; Robin G Bombardi; Andre Branchizio; Nurgun Kose; Pranathi Matta; Alexander M Sevy; Robert S Sinkovits; Pavlo Gilchuk; Jessica A Finn; James E Crowe Journal: Nature Date: 2019-02-13 Impact factor: 49.962
Authors: Ke Li; Rebecca L Johnson; Shiyong Li; John A Thorson; Carolyn M Mulroney; Marie L Dell'Aquila; Huan-You Wang Journal: Int J Clin Exp Pathol Date: 2014-07-15